yangshenguo guanxin

Yangshenguo Guanxin is a botanical drug candidate developed by the Institute of Regenerative Medicine at Jilin University, primarily derived from the fruit of *Viburnum sargentii* Koehne (locally referred to as Yangshenguo). It is specifically designed for the treatment of coronary heart disease and angina pectoris. The therapeutic effects of the drug are attributed to its ability to improve myocardial blood supply and reduce myocardial oxygen consumption, likely through the action of bioactive flavonoids and polyphenols. Preclinical and clinical research conducted at Jilin University suggests that the extract provides significant cardioprotection by stabilizing vascular endothelial cells and mitigating oxidative stress-induced damage in the myocardium.

Brand names

Yangshenguo Guanxin

Other names

Yangshenguo Guanxin CapsuleViburnum sargentii extract养生果冠心